Published in J Neurovirol on April 01, 2004
HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci (2008) 1.37
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol (2006) 1.21
Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci (2009) 1.18
Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res (2011) 1.13
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology (2013) 1.09
Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol (2007) 0.89
Chronic cocaine exposure in the SCID mouse model of HIV encephalitis. Brain Res (2006) 0.80
A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors. J Neuropathol Exp Neurol (2009) 0.80
Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol (2012) 0.77
Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci (2005) 2.17
Homer proteins regulate sensitivity to cocaine. Neuron (2004) 1.83
Repeated cycles of chronic intermittent ethanol exposure in mice increases voluntary ethanol drinking and ethanol concentrations in the nucleus accumbens. Psychopharmacology (Berl) (2008) 1.76
HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci (2008) 1.37
Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. Drug Alcohol Depend (2006) 1.33
Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcohol Clin Exp Res (2006) 1.21
Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci (2009) 1.18
Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol (2006) 1.11
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology (2013) 1.09
Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res (2005) 1.08
Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci (2007) 1.07
Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain. AIDS (2007) 1.06
Impact of sex: determination of alcohol neuroadaptation and reinforcement. Alcohol Clin Exp Res (2006) 1.01
Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol (2007) 1.01
Voluntary ethanol drinking in mice and ethanol concentrations in the nucleus accumbens. Brain Res (2006) 0.98
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann Neurol (2005) 0.98
Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res (2002) 0.97
Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse (2007) 0.95
Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem (2005) 0.95
Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol (2007) 0.94
The interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in mice. Pharmacol Biochem Behav (2010) 0.92
Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol (2007) 0.89
Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol (2010) 0.88
Conditioned stimulus-induced reinstatement of extinguished cocaine seeking in C57BL/6 mice: a mouse model of drug relapse. Brain Res (2003) 0.88
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos (2006) 0.87
Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice. Psychopharmacology (Berl) (2012) 0.87
A dual-hit animal model for age-related parkinsonism. Prog Neurobiol (2009) 0.85
Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging (2010) 0.85
Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice. Behav Pharmacol (2012) 0.84
Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis (2008) 0.83
Evidence for a relationship between Group 1 mGluR hypofunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice. Ann N Y Acad Sci (2003) 0.82
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol (2010) 0.81
Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res (2008) 0.81
The dopamine D1 antagonist reduces ethanol reward for C57BL/6 mice. Alcohol Clin Exp Res (2004) 0.81
Differential neurosensitivity to the discriminative stimulus properties of ethanol in C57BL/6J and C3H/He mice. Alcohol Clin Exp Res (2004) 0.81
Tiagabine reduces ethanol reward in C57BL/6 mice under acute and chronic administration regimens. Synapse (2005) 0.80
The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur J Neurosci (2008) 0.80
The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model. J Interferon Cytokine Res (2014) 0.80
The discriminative stimulus properties of methylphenidate in C57BL/6J mice. Behav Pharmacol (2011) 0.79
Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. J Neurovirol (2014) 0.79
Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor. J Interferon Cytokine Res (2014) 0.78
Neurosarcoidosis. Curr Treat Options Neurol (2007) 0.75
Therapeutic options in neurosarcoidosis. Expert Rev Neurother (2002) 0.75